Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Heritage Distilling Co. Announces Sell Out of First Run of 80th Anniversary of the Battle of Iwo Jima Bourbon; Announces Passing $200,000 Raised for Military Charities
-
NorthStar Courier Expands Fleet with Additional Workhorse W56 Electric Step Van
-
Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment
-
Myriad Genetics Included in Forbes America’s Best Employers 2025 List
-
SecureTech Completes Phase 1 of Share Reduction Program
-
Annovis to Host Patients’ Live Forum on February 27, 2025
-
Fluent, Inc. Appoints Adrian Stack as Chief Product Officer; Accelerates AI-Powered Innovation in Commerce Media
-
Inuvo to Host Fourth Quarter and Year End 2024 Financial Results Conference Call on Thursday, February 27th at 4:15 P.M. EST
-
Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025
-
Nexxen to Announce Fourth Quarter 2024 Financial Results on March 5, 2025
-
Orion Commences $3M in Turnkey, Energy-Efficient LED Lighting Retrofits and Electrical Infrastructure Upgrades for Federal Agency
-
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
-
Form 8.3 - [ALLIANCE PHARMA PLC - 18 02 2025] - (CGWL)
-
Progressive Reports January 2025 Results
-
HUB Cyber Security Secures Six-Month Extension on $11M Notes, and Strengthens Shareholder Equity
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 18 02 2025] - (CGWL)
-
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
-
Rumble and TRUTH Social Sue Brazilian Judge Over Censorship Orders Targeting U.S. Users
-
Data443 Partners with TierPoint to Expand Data Center Footprint
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
ChainSwap Set To Release Telegram Chaining Bot for Cross-Chain DeFi in Q1 2025
-
Invesco Ltd: Form 8.3 - American Axle & Manufacturing Holdings Inc; Public dealing disclosure
-
IMUNON Announces Translational Data from Phase 1/2 OVATION 2 Study of IMNN-001 in Advanced Ovarian Cancer
-
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
-
Laidlaw & Co. Announces Appointment of Douglas M. Jacoby to General Counsel
-
Laidlaw & Co. Announces Appointment of Douglas M. Jacoby to General Counsel
-
Oxford Lane Capital Corp. Announces Offering of Notes
-
Form 8.3 - Renewi Plc
-
Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference
-
4DMT to Participate in Upcoming Investor Conferences
-
LM Funding America, Inc. Upgrades Fleet Efficiency and Hashrate with Luxor Firmware by 10-15%
-
Dawn Project Safety tests reveal that Tesla Full Self-Driving illegally overtakes stopped school buses and runs down children crossing the road
-
BranchOut Food Welcomes Jesse Thomas as Chief Brand Officer to Drive Direct-to-Consumer and Brand Strategy
-
360 Broadband Secures $52M Grant to Expand Internet Access in Fannin County, Texas
-
iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025
-
Torr Metals Identifies >3 Kilometer Geophysical Trend Coincident with Historical High-Grade Gold Mineralization at Filion
-
Greenridge Exploration Confirms High-Grade Uranium on its Nut Lake Uranium Project, including a 31.13% U3O8 sample at its Tundra Showing
-
Recce Pharmaceuticals Reports Positive Data from Phase II Trial of RECCE® 327 Gel in Acute Bacterial Skin and Skin Structure Infections, Supporting Accelerated Commercialization Pathway
-
NEXE Innovations Makes Third Delivery to Bridgehead Coffee
-
LGI Homes Opens New Section at Homestead Estates in Elgin, Texas
-
Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26
-
Atrandi Biosciences Raises $25M Series A Led by Lux Capital to Drive the Future of Single-Cell Multiomics with Semi-Permeable Capsule Technology
-
Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil
-
EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthr
-
VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis
-
REPEAT: Rocket Doctor Signs Agreement with California Managed Care Plan
-
Hobson & Company Analysis of KnowBe4 Finds 200-400% ROI in Reducing Human Risk
-
MAX Power Retains CLC For Investor Relations
-
electroCore’s Truvaga™ Now Available on Amazon®
-
CMO Council Publishes New Index of Marketing Vitality

